Langerhans cells migrate to their final destination in multiple waves at different stages of embryonic development

August 29, 2012
Developmental biology: A tale of two sites
Fluorescence microscopy reveals Langerhans cells (green)  in the epidermis (red, with cell nuclei stained blue). © 2004 Jean Davoust/Florent Ginhoux

As our primary interface with the outside world, the skin needs to be able to protect itself against infectious threats. Specialized cells known as Langerhans cells (LCs) (see image) are an essential component of this defense, helping other immune cells to distinguish friend from foe. "These cells play an important role in maintaining tolerance to cutaneous antigen, while simultaneously promoting immune responses against any invading pathogens," explains Florent Ginhoux at the A*STAR Singapore Immunology Network.

LCs are the skin-based counterparts of (DCs), which reside in all tissues. However, LCs and tissue DCs are generated via distinct developmental pathways, and new research from Ginhoux and co-workers has uncovered unexpected complexity in the process by which the adult LC population arises over time.

Unlike DCs, which are generated continuously from prior to their entry in the and tissues, LCs are instead replenished by local precursors in the skin. In this sense, LCs are similar to microglia, residing exclusively in the brain, and Ginhoux suspected the two otherwise-similar cell types might arise from a common embryonic source. "We had previously shown that microglia derive from yolk sac progenitors," he says. "We hypothesized that LCs could be derived from yolk sac progenitors as well."

To test this model, the researchers used a genetic labeling strategy to trace the development of different cells in mouse embryos. Indeed, they confirmed that LCs are generated by precursors in the yolk sac, which migrate to the skin around the tenth day of mouse embryonic development, a process that requires 20 days in full. However, they were surprised to find that these yolk sac-derived cells form less than 10% of the adult LC population.

In fact, further lineage-tracing experiments revealed a later, larger wave of LC formation in the fetal liver, producing cells that migrate to the skin between the thirteenth and seventeenth day of . "It was unexpected to find that the fetal liver contribution superseded that of the yolk sac," says Ginhoux. He notes that although both microglia and LCs appear to emerge from common progenitors in the yolk sac, the subsequent formation of the blood-brain barrier would most likely prevent equivalent migration of liver-derived microglial precursors to the brain.

This two-wave developmental process thus appears to be specifically limited to LCs, and Ginhoux and co-workers now hope to determine what, if any, functional value is gained by this stepwise developmental process.

Explore further: Mystery to the origin of long-lived, skin-deep immune cells uncovered

More information: Hoeffel, G., Wang, Y., Greter, M., See, P., Teo, P., et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac–derived macrophages. Journal of Experimental Medicine 209, 1167–1181 (2012). Article

Related Stories

Mystery to the origin of long-lived, skin-deep immune cells uncovered

June 7, 2012
Scientists at A*STAR’s Singapore Immunology Network (SIgN) uncovered the origin of a group of skin-deep immune cells that act as the first line of defence against harmful germs and skin infections. SIgN scientists discovered ...

Double duty: Versatile immune cells play dual roles in human skin

May 3, 2012
A new study helps to resolve an ongoing controversy about whether Langerhans cells (LCs) in human skin function to suppress the immune response and promote tolerance to normal human skin and its "friendly" microbial flora ...

New path of origin for macrophages

May 2, 2012
Macrophages play a key role in the immune response, protecting organisms against infection and regulating the development of inflammation in tissue. Macrophages differ depending on where they are located and which tasks they ...

Scientists discover dendritic cells key to activating human immune responses

July 16, 2012
Scientists at A*STAR’s Singapore Immunology Network (SIgN), in collaboration with Newcastle University, UK, the Singapore Institute of Clinical Sciences and clinicians from multiple hospitals in Singapore, have identified ...

Recommended for you

Estrogen discovery could shed new light on fertility problems

December 12, 2017
Estrogen produced in the brain is necessary for ovulation in monkeys, according to researchers at the University of Wisconsin-Madison who have upended the traditional understanding of the hormonal cascade that leads to release ...

Time of day affects severity of autoimmune disease

December 12, 2017
Insights into how the body clock and time of day influence immune responses are revealed today in a study published in leading international journal Nature Communications. Understanding the effect of the interplay between ...

3-D printed microfibers could provide structure for artificially grown body parts

December 12, 2017
Much as a frame provides structural support for a house and the chassis provides strength and shape for a car, a team of Penn State engineers believe they have a way to create the structural framework for growing living tissue ...

Team identifies DNA element that may cause rare movement disorder

December 11, 2017
A team of Massachusetts General Hospital (MGH) researchers has identified a specific genetic change that may be the cause of a rare but severe neurological disorder called X-linked dystonia parkinsonism (XDP). Occurring only ...

Protein Daple coordinates single-cell and organ-wide directionality in the inner ear

December 11, 2017
Humans inherited the capacity to hear sounds thanks to structures that evolved millions of years ago. Sensory "hair cells" in the inner ear have the amazing ability to convert sound waves into electrical signals and transmit ...

Gene therapy improves immunity in babies with 'bubble boy' disease

December 9, 2017
Early evidence suggests that gene therapy developed at St. Jude Children's Research Hospital will lead to broad protection for infants with the devastating immune disorder X-linked severe combined immunodeficiency disorder. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.